Provided by Tiger Trade Technology Pte. Ltd.

Atara Biotherapeutics

10.11
+0.67007.10%
Post-market: 9.96-0.1500-1.48%19:30 EDT
Volume:116.75K
Turnover:1.16M
Market Cap:101.48M
PE:-8.50
High:10.37
Open:9.50
Low:9.07
Close:9.44
52wk High:19.15
52wk Low:3.92
Shares:10.04M
Float Shares:4.62M
Volume Ratio:2.72
T/O Rate:2.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1889
EPS(LYR):2.57
ROE:-2014.86%
ROA:-24.14%
PB:-2.74
PE(LYR):3.93

Loading ...

Atara Biotherapeutics Adds Independent Director to Board

TIPRANKS
·
Jun 13

Atara Biotherapeutics names Brian Cherry to board of directors

Reuters
·
Jun 13

Atara Biotherapeutics Announces Changes to Its Board of Directors

THOMSON REUTERS
·
Jun 13

Top Atara Biotherapeutics Executives Quietly Cash Out in Latest Insider Moves

TIPRANKS
·
May 21

Atara Biotherapeutics Raised to Hold From Sell by Freedom Broker

Dow Jones
·
May 19

Atara Biotherapeutics upgraded to Hold from Sell at Freedom Broker

TIPRANKS
·
May 18

Manufacturing and Supply-Chain Risks Threaten Atara Biotherapeutics’ Cell Therapy Pipeline

TIPRANKS
·
May 14

Atara Biotherapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Atara Biotherapeutics (ATRA) Receives a Buy from Canaccord Genuity

TIPRANKS
·
May 13

Atara Biotherapeutics reports Q1 EPS -29c, consensus -22c

TIPRANKS
·
May 13

Atara Biotherapeutics Q1 EPS $(0.29) Beats $(0.41) Estimate, Sales $516.000K Miss $2.850M Estimate

Benzinga Earnings
·
May 13

Atara Biotherapeutics Inc - May Offer up to $79.27 Mln in Common Stock as of May 12, 2026 - SEC Filing

THOMSON REUTERS
·
May 13

Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain

Reuters
·
May 13

Atara Biotherapeutics turns to Q1 FY26 net loss of $4.1 million; revenue falls to $516,000

Reuters
·
May 13

BRIEF-Atara Biotherapeutics Q1 EPS USD -0.29

Reuters
·
May 13

Atara Biotherapeutics Q1 Revenue USD 516 Thousand

THOMSON REUTERS
·
May 13

Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational Progress

THOMSON REUTERS
·
May 13

Panacea Innovation reports Atara Biotherapeutics share disposal worth $3,164,347.94

Reuters
·
May 12

Atara Biotherapeutics: EcoR1 Capital files initial beneficial ownership statement

Reuters
·
May 12

Atara Biotherapeutics Inc expected to post a loss of 40 cents a share - Earnings Preview

Reuters
·
May 11